Finance

Lists
Why is 08HH down 2,09%?
Dive Deeper
08HH:FRA
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
1,99 €
-2,09%
(-0,043) 1D
9 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 08HH...
Open
1,99 €
High
1,99 €
Low
1,99 €
Mkt. cap
68,55 մլրդ
Avg. vol.
862,00
Volume
0,00
52-wk high
2,87 €
52-wk low
1,66 €
No. of employees
41 հզր
Open
1,99 €
High
1,99 €
Low
1,99 €
Mkt. cap
68,55 մլրդ
Avg. vol.
862,00
Volume
0,00
52-wk high
2,87 €
52-wk low
1,66 €
No. of employees
41 հզր
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40,7 հզր
Founded1994
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
9,88 մլրդ
12,27 մլրդ
10,07 մլրդ
10,37 մլրդ
Cost of goods sold
5,08 մլրդ
5,65 մլրդ
5,07 մլրդ
5,23 մլրդ
Cost of revenue
5,08 մլրդ
5,65 մլրդ
5,07 մլրդ
5,23 մլրդ
Research and development expenses
1,01 մլրդ
1,28 մլրդ
896,79 մլն
1,19 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 մլրդ
4,44 մլրդ
3,27 մլրդ
3,35 մլրդ
Operating expense
4,04 մլրդ
5,92 մլրդ
4,19 մլրդ
4,63 մլրդ
Total operating expenses
9,12 մլրդ
11,57 մլրդ
9,26 մլրդ
9,86 մլրդ
Operating income
758,38 մլն
699,05 մլն
813,78 մլն
505,27 մլն
Other non operating income
-116,85 մլն
107,33 մլն
2,03 մլն
-13,28 մլն
EBT including unusual items
1,12 մլրդ
1,27 մլրդ
1,36 մլրդ
1,23 մլրդ
EBT excluding unusual items
1,49 մլրդ
1,10 մլրդ
1,21 մլրդ
1,07 մլրդ
Income tax expense
162,98 մլն
82,80 մլն
277,92 մլն
159,73 մլն
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 մլն
117,57 մլն
19,04 մլն
74,01 մլն
Net income
821,33 մլն
847,27 մլն
870,83 մլն
850,64 մլն
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 մլրդ
732,13 մլն
689,67 մլն
938,86 մլն
Interest expense
-321,25 մլն
-291,32 մլն
-296,51 մլն
-310,88 մլն
Net interest expenses
727,28 մլն
440,80 մլն
393,16 մլն
627,98 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 մլրդ
1,47 մլրդ
1,59 մլրդ
1,24 մլրդ
Gain or loss from assets sale
2,12 մլն
-69,35 մլն
-
-195,23 հզր
AI content may include mistakes. Learn more
Google Apps